By Professor Bruce Neal

Journal articles

Shahid M; Gaines A; Coyle D; Alessandrini R; Finnigan T; Frost G; Marklund M; Neal B, 2023, 'P29-040-23 The Effect of Mycoprotein Intake on Biomarkers of Human Health: A Systematic Review and Meta-Analysis', Current Developments in Nutrition, 7, pp. 101428 - 101428, http://dx.doi.org/10.1016/j.cdnut.2023.101428

Carcel C; Neal B; Rogers K; Oparil S; Narkiewicz K; Wang J; Schiffrin EL; Azizi M; Poulter N; Chalmers J, 2023, 'S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL', Journal of Hypertension, 41, pp. e42, http://dx.doi.org/10.1097/01.hjh.0000913112.64878.4e

Jain SS; Yu J; Arnott C; Neal BC; Perkovic V; Neuen B; Jardine M; Mahaffey KW, 2023, 'TREATMENT EFFECT OF CANAGLIFLOZIN FOR PATIENTS ON THERAPY FOR HEART FAILURE: POOLED ANALYSIS OF THE CANVAS PROGRAM AND CREDENCE TRIAL', Journal of the American College of Cardiology, 81, pp. 283, http://dx.doi.org/10.1016/s0735-1097(23)00727-1

Rasmussen DGK; Hansen MK; Blair J; Jatkoe TA; Neal B; Karsdal MA; Genovese F, 2022, 'Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial', Cardiovascular Diabetology, 21, pp. 261, http://dx.doi.org/10.1186/s12933-022-01666-7

Tye SC; Jongs N; Coca SG; Sundström J; Arnott C; Neal B; Perkovic V; Mahaffey KW; Vart P; Heerspink HJL, 2022, 'Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure', Cardiovascular Diabetology, 21, pp. 194, http://dx.doi.org/10.1186/s12933-022-01619-0

Coyle DH; Huang L; Shahid M; Gaines A; Di Tanna GL; Louie JCY; Pan X; Marklund M; Neal B; Wu JHY, 2022, 'Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel', International Journal of Behavioral Nutrition and Physical Activity, 19, pp. 148, http://dx.doi.org/10.1186/s12966-022-01389-8

Crosby S; Rajadurai E; Jan S; Holden R; Neal B, 2022, 'The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review', Humanities and Social Sciences Communications, 9, pp. 266, http://dx.doi.org/10.1057/s41599-022-01269-3

Baigent C; Emberson JR; Haynes R; Herrington WG; Judge P; Landray MJ; Mayne KJ; Ng SYA; Preiss D; Roddick AJ; Staplin N; Zhu D; Anker SD; Bhatt DL; Brueckmann M; Butler J; Cherney DZI; Green JB; Hauske SJ; Heerspink HJL; Inzucchi SE; Jardine MJ; Liu CC; Mahaffey KW; McCausland FR; McGuire DK; McMurray JJV; Neal B; Neuen BL; Packer M; Perkovic V; Sabatine MS; Solomon SD; Vaduganathan M; Wanner C; Wheeler DC; Wiviott SD; Zannad F, 2022, 'Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials', The Lancet, 400, pp. 1788 - 1801, http://dx.doi.org/10.1016/S0140-6736(22)02074-8

Sarraju A; Bakris G; Cannon CP; Cherney D; Damaraju CV; Figtree GA; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Neal B; Jardine MJ; Blais J; Kosiborod M; Levin A; Lingvay I; Weir MR; Perkovic V; Mahaffey KW, 2022, 'Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria', Journal of the American College of Cardiology, 80, pp. 1721 - 1731, http://dx.doi.org/10.1016/j.jacc.2022.08.772

Koshino A; Schechter M; Sen T; Vart P; Neuen BL; Neal B; Arnott C; Perkovic V; Ridker PM; Tuttle KR; Hansen MK; Heerspink HJL, 2022, 'Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS', Diabetes Care, 45, pp. 2644 - 2652, http://dx.doi.org/10.2337/dc22-0866

Wu JHY; Trieu K; Coyle D; Huang L; Wijesuriya N; Nallaiah K; Lung T; Di Tanna GL; Zheng M; Mozaffarian D; MacMillan F; Simmons D; Wu T; Twigg S; Gauld A; Constantino M; McGill M; Wong J; Neal B, 2022, 'Testing the Feasibility and Dietary Impact of a “Produce Prescription” Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia', Journal of Nutrition, 152, pp. 2409 - 2418, http://dx.doi.org/10.1093/jn/nxac152

Li C; Yu J; Hockham C; Perkovic V; Neuen BL; Badve SV; Houston L; Lee VYJ; Barraclough JY; Fletcher RA; Mahaffey KW; Heerspink HJL; Cannon CP; Neal B; Arnott C, 2022, 'Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis', Diabetes, Obesity and Metabolism, 24, pp. 1927 - 1938, http://dx.doi.org/10.1111/dom.14772

Yin X; Rodgers A; Perkovic A; Huang L; Li KC; Yu J; Wu Y; Wu JHY; Marklund M; Huffman MD; Miranda JJ; Di Tanna GL; Labarthe D; Elliott P; Tian M; Neal B, 2022, 'Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis', Heart, 108, pp. 1608 - 1615, http://dx.doi.org/10.1136/heartjnl-2022-321332

Marklund M; Tullu F; Thout SR; Yu J; Brady TM; Appel LJ; Neal B; Wu JHY; Gupta R, 2022, 'Estimated Benefits and Risks of Using a Reduced-Sodium, Potassium-Enriched Salt Substitute in India: A Modeling Study', Hypertension, 79, pp. 2188 - 2198, http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.19072

Sen T; Koshino A; Neal B; Bijlsma MJ; Arnott C; Li J; Hansen MK; Ix JH; Heerspink HJL, 2022, 'Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial', Diabetes, Obesity and Metabolism, 24, pp. 1950 - 1956, http://dx.doi.org/10.1111/dom.14779

Maganja D; Trieu K; Reading M; Huang L; Hart AC; Taylor F; Stamatellis S; Arnott C; Feng X; Schutte AE; Di Tanna GL; Ni Mhurchu C; Cameron AJ; Huffman MD; Neal B; Wu JH, 2022, 'Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial', American Heart Journal, 252, pp. 70 - 83, http://dx.doi.org/10.1016/j.ahj.2022.06.007

Arnott C; Fletcher RA; Neal B, 2022, 'Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk', Heart Failure Clinics, 18, pp. 645 - 654, http://dx.doi.org/10.1016/j.hfc.2022.03.008

Nadkarni GN; Takale D; Neal B; Mahaffey KW; Yavin Y; Hansen MK; Fleming F; Heerspink HJL; Coca SG, 2022, 'A Post Hoc Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease', Kidney360, 3, pp. 1599 - 1602, http://dx.doi.org/10.34067/KID.0002172022

Liu Y; Xiao S; Yin X; Gao P; Wu J; Xiong S; Hockham C; Hone T; Wu JHY; Pearson SA; Neal B; Tian M, 2022, 'Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review', Public Health Reviews, 43, pp. 1605025, http://dx.doi.org/10.3389/phrs.2022.1605025

Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K; Agodoa L; Algra A; Asselbergs FW; Beckett N; Berge E; Black H; Brouwers FPJ; Brown M; Bulpitt CJ; Byington B; Cutler J; Devereaux RB; Dwyer J; Estacio R; Fagard R; Fox K; Fukui T; Imai Y; Ishii M; Julius S; Kanno Y; Kjeldsen SE; Kostis J; Kuramoto K; Lanke J; Lewis E; Lewis J; Lievre M; Lindholm LH; Lueders S; MacMahon S; Mancia G; Matsuzaki M; Mehlum MH; Nissen S; Ogawa H; Ogihara T; Ohkubo T; Palmer C; Patel A; Pfeffer M; Poulter NR; Rakugi H; Reboldi G; Reid C; Remuzzi G; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen JA; Suzuki H; Thijs L; Ueshima K; Umemoto S; van Gilst WH; Verdecchia P; Wachtell K; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A; Zhang ZY; Anderson C; Baigent C; Brenner BM; Collins R; de Zeeuw D; Lubsen J; Malacco E; Neal B; Perkovic V; Pitt B; Rodgers A; Rothwell P; Salimi-Khorshidi G; Sundström J, 2022, 'Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis', The Lancet Diabetes and Endocrinology, 10, pp. 645 - 654, http://dx.doi.org/10.1016/S2213-8587(22)00172-3

Crosby S; Rajadurai E; Jan S; Neal B; Holden R, 2022, 'The effects on clinical trial activity of direct funding and taxation policy interventions made by government: A systematic review', PLoS ONE, 17, pp. e0269021, http://dx.doi.org/10.1371/journal.pone.0269021

Bablani L; Ni Mhurchu C; Neal B; Skeels CL; Staub KE; Blakely T, 2022, 'Effect of voluntary Health Star Rating labels on healthier food purchasing in New Zealand: Longitudinal evidence using representative household purchase data', BMJ Nutrition, Prevention and Health, 5, pp. 227 - 234, http://dx.doi.org/10.1136/bmjnph-2022-000459

Li JW; Arnott C; Heerspink HJL; Mbiostat QL; Cannon CP; Wheeler DC; Charytan DM; Barraclough J; Figtree GA; Agarwal R; Bakris G; de Zeeuw D; Greene T; Levin A; Pollock C; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Neal B; Jardine MJ, 2022, 'Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial', Journal of the American Heart Association, 11, pp. e025045, http://dx.doi.org/10.1161/JAHA.121.025045

Ferrannini E; Baldi S; Scozzaro T; Tsimihodimos V; Tesfaye F; Shaw W; Rosenthal N; Figtree GA; Neal B; Mahaffey KW; Perkovic V; Hansen MK, 2022, 'Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)', Diabetes Care, 45, pp. 1893 - 1899, http://dx.doi.org/10.2337/dc21-2398

Juraschek SP; Wang D; McEvoy JW; Harrap S; Harris K; Mancia G; Marre M; Neal B; Patel A; Poulter NR; Williams B; Chalmers J; Woodward M; Selvin E, 2022, 'Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE', International Journal of Cardiology, 358, pp. 103 - 109, http://dx.doi.org/10.1016/j.ijcard.2022.04.044

Liao J; Kang A; Xia C; Young T; Di Tanna GL; Arnott C; Pollock C; Krishnan AV; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Heerspink HJL; Levin A; Neal B; Wheeler DC; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ; Smyth B, 2022, 'The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial', Diabetes and Metabolism, 48, pp. 101331, http://dx.doi.org/10.1016/j.diabet.2022.101331

Barraclough JY; Yu J; Figtree GA; Perkovic V; Heerspink HJL; Neuen BL; Cannon CP; Mahaffey KW; Schutte AE; Neal B; Arnott C, 2022, 'Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 24, pp. 1072 - 1083, http://dx.doi.org/10.1111/dom.14671

Li KC; Huang L; Tian M; Di Tanna GL; Yu J; Zhang X; Yin X; Liu Y; Hao Z; Zhou B; Feng X; Li Z; Zhang J; Sun J; Zhang Y; Zhao Y; Zhang R; Yu Y; Li N; Yan LL; Labarthe DR; Elliott P; Wu Y; Neal B; Lung T; Si L, 2022, 'Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study', Circulation, 145, pp. 1534 - 1541, http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059573

Neuen BL; Oshima M; Agarwal R; Arnott C; Cherney DZ; Edwards R; Langkilde AM; Mahaffey KW; McGuire DK; Neal B; Perkovic V; Pong A; Sabatine MS; Raz I; Toyama T; Wanner C; Wheeler DC; Wiviott SD; Zinman B; Heerspink HJL, 2022, 'Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized, Controlled Trials', Circulation, 145, pp. 1460 - 1470, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057736

Schutte AE; Neal B, 2022, 'The sodium hidden in medication: a tough pill to swallow', European Heart Journal, 43, pp. 1756 - 1758, http://dx.doi.org/10.1093/eurheartj/ehab888

Bhat S; Coyle DH; Trieu K; Neal B; Mozaffarian D; Marklund M; Wu JHY, 2022, 'Reply to A Coskun and B Oz', Advances in Nutrition, 13, pp. 692 - 693, http://dx.doi.org/10.1093/advances/nmac005

Vaduganathan M; Sattar N; Xu J; Butler J; Mahaffey KW; Neal B; Shaw W; Rosenthal N; Pfeifer M; Hansen MK; Januzzi JL, 2022, 'Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin', Journal of the American College of Cardiology, 79, pp. 432 - 444, http://dx.doi.org/10.1016/j.jacc.2021.11.027

Waijer SW; Sen T; Arnott C; Neal B; Kosterink JGW; Mahaffey KW; Parikh CR; de Zeeuw D; Perkovic V; Neuen BL; Coca SG; Hansen MK; Gansevoort RT; Heerspink HJL, 2022, 'Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease', Clinical Journal of the American Society of Nephrology, 17, pp. 251 - 259, http://dx.doi.org/10.2215/CJN.08780621

Heerspink HJL; Oshima M; Zhang H; Li J; Agarwal R; Capuano G; Charytan DM; Craig J; de Zeeuw D; Di Tanna GL; Levin A; Neal B; Perkovic V; Wheeler DC; Yavin Y; Jardine MJ, 2022, 'Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial', American Journal of Kidney Diseases, 79, pp. 244 - 256.e1, http://dx.doi.org/10.1053/j.ajkd.2021.05.005

Coyle DH; Shahid M; Dunford EK; Ni Mhurchu C; Scapin T; Trieu K; Marklund M; Chun Yu Louie J; Neal B; Wu JHY, 2022, 'The Contribution of Major Food Categories and Companies to Household Purchases of Added Sugar in Australia', Journal of the Academy of Nutrition and Dietetics, 122, pp. 345 - 353.e3, http://dx.doi.org/10.1016/j.jand.2021.06.013

Campbell NRC; Whelton PK; Orias M; Wainford RD; Cappuccio FP; Ide N; Neal B; Cohn J; Cobb LK; Webster J; Trieu K; He FJ; McLean RM; Blanco-Metzler A; Woodward M; Khan N; Kokubo Y; Nederveen L; Arcand JA; MacGregor GA; Owolabi MO; Lisheng L; Parati G; Lackland DT; Charchar FJ; Williams B; Tomaszewski M; Romero CA; Champagne B; L’Abbe MR; Weber MA; Schlaich MP; Fogo A; Feigin VL; Akinyemi R; Inserra F; Menon B; Simas M; Neves MF; Hristova K; Pullen C; Pandeya S; Ge J; Jalil JE; Wang JG; Wideimsky J; Kreutz R; Wenzel U; Stowasser M; Arango M; Protogerou A; Gkaliagkousi E; Fuchs FD; Patil M; Chan AWK; Nemcsik J; Tsuyuki RT; Narasingan SN; Sarrafzadegan N; Ramos ME; Yeo N; Rakugi H; Ramirez AJ; Álvarez G; Berbari A; Kim CI; Ihm SH; Chia YC; Unurjargal T; Park HK; Wahab K; McGuire H; Dashdorj NJ; Ishaq M; Ona DID; Mercado-Asis LB; Prejbisz A; Leenaerts M; Simão C; Pinto F; Almustafa BA; Spaak J; Farsky S; Lovic D; Zhang XH, 2022, '2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action', Journal of Human Hypertension, 37, http://dx.doi.org/10.1038/s41371-022-00690-0

Canoy D; Copland E; Nazarzadeh M; Ramakrishnan R; Pinho-Gomes AC; Salam A; Dwyer JP; Farzadfar F; Sundström J; Woodward M; Davis BR; Rahimi K; Neal B; Abdul Salam M, 2022, 'Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials', Heart, 108, pp. 1281 - 1289, http://dx.doi.org/10.1136/heartjnl-2021-320171

Lam D; Nadkarni GN; Mosoyan G; Neal B; Mahaffey KW; Rosenthal N; Hansen MK; Heerspink HJL; Fleming F; Coca SG, 2022, 'Clinical utility of KidneyIntelX in early stages of diabetic kidney disease in the CANVAS trial', American Journal of Nephrology, 53, pp. 21 - 31, http://dx.doi.org/10.1159/000519920

Li JW; Guo YT; Di Tanna GL; Neal B; Chen YD; Schutte AE, 2022, 'Erratum: Vital Signs During the COVID-19 Outbreak: A Retrospective Analysis of 19,960 Participants in Wuhan and Four Nearby Capital Cities in China (Global Heart (2021) 16: 1 (47) DOI: 10.5334/gh.913)', Global Heart, 17, pp. 88, http://dx.doi.org/10.5334/GH.1172

Bowman L; Weidinger F; Albert MA; Fry ETA; Pinto FJ; Achenbach S; Casadei B; Collins R; Devereaux PJ; Douglas PS; Frobert O; Goto S; Grines C; Harrington RA; Haynes R; Hochman JS; James S; Kirchhof P; Komajda M; Lam CSP; Landray M; Maggioni A; McMurray J; Medhurst N; Mehran R; Neal B; Rydén L; Thiele H; Van Gelder I; Wallentin L; Yusuf S; Zannad F, 2022, 'Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation', Global Heart, 17, pp. 85, http://dx.doi.org/10.5334/GH.1178

Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Heerspink HJ; Neal B; Jun M; Rodgers A; Perkovic V; Neuen B, 2022, 'Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials', Hypertension, 79, http://dx.doi.org/10.1161/hyp.79.suppl_1.p201

Wu JH; Trieu K; Coyle D; Huang L; Wijesuriya N; Nallaiah K; Lung T; Di Tanna GL; Zheng M; Mozaffarian D; MacMillan F; Simmons D; Wu T; Twigg S; Gauld A; Constantino M; McGill M; Wong J; Neal B, 2022, 'Testing the Feasibility and Dietary Impact of a "Produce Prescription" Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia.', J Nutr, 152, pp. 2409 - 2418, http://dx.doi.org/10.1093/jn/nxac152

Neal B; Tian M; Wu Y, 2021, 'Salt Substitute and Cardiovascular Events and Death. Reply', The New England journal of medicine, 385, pp. 2493 - 2494, http://dx.doi.org/10.1056/NEJMc2116824

Neuen BL; Oshima M; Perkovic V; Agarwal R; Arnott C; Bakris G; Cannon CP; Charytan DM; Edwards R; Górriz JL; Jardine MJ; Levin A; Neal B; De Nicola L; Pollock C; Rosenthal N; Wheeler DC; Mahaffey KW; Heerspink HJL, 2021, 'Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial', European Heart Journal, 42, pp. 4891 - 4901, http://dx.doi.org/10.1093/eurheartj/ehab497

Liu Y; Chu H; Peng K; Yin X; Huang L; Wu Y; Pearson SA; Li N; Elliott P; Yan LL; Labarthe DR; Hao Z; Feng X; Zhang J; Zhang Y; Zhang R; Zhou B; Li Z; Sun J; Zhao Y; Yu Y; Tian M; Neal B; Liu H, 2021, 'Factors Associated with the Use of a Salt Substitute in Rural China', JAMA Network Open, 4, pp. e2137745, http://dx.doi.org/10.1001/jamanetworkopen.2021.37745

Sen T; Li J; Neuen BL; Arnott C; Neal B; Perkovic V; Mahaffey KW; Shaw W; Canovatchel W; Hansen MK; Heerspink HJL, 2021, 'Association between circulating gdf-15 and cardio-renal outcomes and effect of canagliflozin: Results from the canvas trial', Journal of the American Heart Association, 10, pp. e021661, http://dx.doi.org/10.1161/JAHA.121.021661

Trevena H; Neal B; Downs SM; Davis T; Sacks G; Crino M; Thow AM, 2021, 'Drawing on Strategic Management Approaches to Inform Nutrition Policy Design: An Applied Policy Analysis for Salt Reduction in Packaged Foods', International journal of health policy and management, 10, pp. 896 - 908, http://dx.doi.org/10.34172/ijhpm.2020.204

Coyle DH; Shahid M; Dunford EK; Louie JCY; Trieu K; Marklund M; Neal B; Wu JHY, 2021, 'Estimating the potential impact of the Australian government’s reformulation targets on household sugar purchases', International Journal of Behavioral Nutrition and Physical Activity, 18, pp. 138, http://dx.doi.org/10.1186/s12966-021-01208-6

Liu Y; Li N; Yan N; Pan XF; Li Q; Micha R; Mozaffarian D; Huffman MD; Wang Y; Neal B; Tian M; Zhao Y; Wu JHY, 2021, 'Protocol for a randomized controlled trial to test the acceptability and adherence to 6-months of walnut supplementation in Chinese adults at high risk of cardiovascular disease', Nutrition Journal, 20, pp. 3, http://dx.doi.org/10.1186/s12937-020-00660-7

Golledge J; Arnott C; Moxon J; Monaghan H; Norman R; Morris D; Li Q; Jones G; Roake J; Bown M; Neal B, 2021, 'Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm', Trials, 22, pp. 962, http://dx.doi.org/10.1186/s13063-021-05915-0

Back to profile page